+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vaginal Antibacterial Gel Market by Active Ingredient, Application, Distribution Channel, End User, Packaging Type, Price Tier - Global Forecast 2025-2030- Product Image
Vaginal Antibacterial Gel Market by Active Ingredient, Application, Distribution Channel, End User, Packaging Type, Price Tier - Global Forecast 2025-2030- Product Image
New

Vaginal Antibacterial Gel Market by Active Ingredient, Application, Distribution Channel, End User, Packaging Type, Price Tier - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138927
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Navigating the Dynamic Terrain of Vaginal Antibacterial Gels with an Authoritative Overview of Market Drivers and Technological Innovations Shaping the Future

Navigating the therapeutic landscape of vaginal antibacterial gels requires an understanding of both clinical imperatives and emerging formulation science. These gels combine targeted antimicrobial activity with mucosal compatibility to address conditions such as bacterial vaginosis and postoperative infection prevention. Their localized delivery mechanism offers an advantage over systemic therapies by concentrating active agents at the site of infection while minimizing systemic exposure.

Advancements in polymer matrices, pH-responsive carriers, and biocompatible excipients have accelerated the development of next-generation gels that prioritize both efficacy and comfort. Concurrently, regulatory authorities are intensifying scrutiny around vaginal health products, enforcing rigorous safety and performance benchmarks. This confluence of scientific innovation and regulatory oversight underscores the strategic importance of robust product pipelines and agile development processes.

By examining the drivers behind antimicrobial selection, patient adherence considerations, and the evolving clinical evidence base, this analysis sets the stage for a comprehensive exploration of transformative trends, tariff impacts, segmentation strategies, regional dynamics, and competitive positioning within the vaginal antibacterial gel space.

Examining the Transformative Shifts in Vaginal Antibacterial Gel Development Driven by Regulatory Milestones, Consumer Expectations, and Scientific Breakthroughs

Over the last several years, the vaginal antibacterial gel sector has undergone significant evolution driven by shifting regulatory frameworks and rising consumer expectations. Regulatory agencies have updated guidelines to demand more stringent biocompatibility assessments and sustainability disclosures. As a result, manufacturers are increasingly integrating eco-friendly packaging materials and conducting extensive in-vitro and in-vivo safety testing to meet the new compliance thresholds.

Simultaneously, consumer preferences are gravitating toward more natural and gentle formulations, prompting research into synergistic blends of established antiseptics with botanical extracts. This consumer-driven emphasis on clean labeling has spurred reformulation initiatives, encouraging cross-disciplinary collaborations between pharmaceutical scientists and natural product chemists.

Furthermore, scientific breakthroughs in nanoparticle delivery and controlled-release matrices are redefining the performance expectations for vaginal gels. These technological shifts are complemented by enhanced digital diagnostic tools that enable personalized treatment regimens. Together, these factors represent a decisive transformation in how vaginal antibacterial gels are conceived, developed, and brought to market.

Assessing the Cumulative Impact of United States Tariffs in 2025 on Production Costs, Supply Chain Dynamics, and Competitive Positioning within the Industry

The implementation of new tariffs in 2025 has created a ripple effect across the supply chain for vaginal antibacterial gel manufacturers. Higher duties on imported active ingredients have prompted organizations to reassess their sourcing strategies, with many exploring domestic production of Benzalkonium Chloride and Chlorhexidine Gluconate to mitigate cost pressures. This shift is leading to increased capital investment in local manufacturing facilities and strategic partnerships with regional chemical producers.

At the same time, import levies on packaging components such as pump dispensers and sachet foil have reinforced the importance of supply chain agility. Companies are responding by diversifying vendor portfolios and renegotiating long-term contracts to secure price stability. As a result, lead times have tightened, emphasizing the need for accurate demand planning and dynamic inventory management.

In parallel, tariff-induced cost increases have influenced competitive positioning, compelling mid-tier and premium brands to refine their value propositions. By optimizing end-to-end operations and leveraging economies of scale, industry leaders are striving to preserve margins and maintain product accessibility for end users across clinics, hospitals, and home care settings.

Unlocking Key Segmentation Insights across Active Ingredients, Application Use Cases, Distribution Pathways, End User Demands, Packaging Formats, and Price Tiers

Active ingredient selection remains a cornerstone of product differentiation. Benzalkonium Chloride offers broad-spectrum efficacy with favorable stability profiles, whereas Chlorhexidine Gluconate provides potent residual activity that can reduce recurrence rates. Povidone Iodine stands out for its rapid germicidal action and established safety record in perioperative applications. Each compound presents unique formulation challenges and performance trade-offs.

Within clinical applications, bacterial vaginosis is addressed through both acute and recurrent treatment protocols, demanding gels with optimized release kinetics to balance immediate relief and long-term microbiome restoration. Postoperative infection prevention and surgical prophylaxis further subdivide into intraoperative and preoperative use cases, each requiring sterile packaging solutions and validated preservative systems.

Distribution pathways range from hospital pharmacies that prioritize rigorous chain-of-custody processes to retail outlets that emphasize consumer convenience, while online pharmacies are redefining last-mile delivery and subscription models. End user environments, including clinics, home care, and hospitals, shape product usage patterns and adherence strategies, influencing design decisions such as single-dose sachets or multipurpose pump dispensers.

Packaging considerations span pump dispensers that facilitate precise dosing, sachets engineered for portability, and traditional tube packs valued for cost-effectiveness. Pricing tiers from economy to premium reflect both formulation complexity and brand positioning, accommodating a spectrum of patient budgets and therapeutic requirements.

Decoding Regional Dynamics Across the Americas, Europe, the Middle East & Africa, and Asia-Pacific to Highlight Growth Drivers and Market Potential

In the Americas, established reimbursement frameworks and advanced clinical infrastructure support rapid adoption of premium vaginal gel formulations. Heightened awareness of women’s health initiatives has spurred collaboration between public health agencies and private manufacturers to expand access in outpatient settings. Digital health platforms are also enhancing patient education and adherence tracking.

Europe, the Middle East & Africa present a mosaic of regulatory environments, where harmonized standards within the EU coexist alongside evolving frameworks in the Middle East and cost-sensitive markets in Africa. Companies operating in this region must balance compliance with varying approval timelines and navigate complex distribution networks to reach both urban hospitals and rural clinics.

Asia-Pacific is characterized by dynamic growth driven by escalating healthcare expenditures and rising infection awareness. Local manufacturing capacity is expanding, supported by government incentives for pharmaceutical innovation. As consumer purchasing power increases, online pharmacy channels are gaining traction, particularly in metropolitan centers where rapid delivery and discreet packaging address privacy concerns.

Profiling Leading Industry Players and Evaluating Their Strategic Initiatives, Partnerships, and Innovative Product Pipelines Shaping Competitive Dynamics

Leading players have adopted diverse strategies to fortify their positions. Johnson & Johnson’s Ethicon division leverages its surgical heritage to enhance gel formulations with proprietary excipient systems, while Becton Dickinson is integrating advanced dispensing technologies to improve dosing accuracy and user ergonomics. Medline Industries focuses on supply chain resilience through vertical integration, ensuring continuity of pump dispenser production and sterile packaging.

Specialty chemical providers such as Saraya are collaborating with third-party manufacturers to advance green chemistry initiatives, reducing solvent use and optimizing polymer crosslinking for improved gel viscosity. Emerging biotech entrants are exploring next-generation antimicrobial peptides and biofilm-disrupting enzymes, aiming to inaugurate a new class of vaginal therapeutics with enhanced safety profiles.

Strategic partnerships are also shaping competitive dynamics. Alliances between pharmaceutical and digital health firms are driving adjunct solutions that integrate telemedicine consultations with gel delivery subscriptions. Meanwhile, select companies are acquiring local niche brands to broaden their geographic footprint and accelerate market entry into underserved regions.

Delivering Actionable Recommendations for Industry Leaders to Optimize Product Portfolios, Streamline Supply Chains, and Accelerate Market Penetration Strategies

To maximize competitive advantage, companies should intensify investment in formulation research that explores synergistic combinations of established antiseptics with novel bioactive compounds. Parallel efforts must focus on sustainable packaging, adopting recyclable pump mechanisms and biodegradable sachet materials to align with environmental mandates and consumer expectations.

Supply chain diversification is critical in an era of tariff volatility. Establishing regional manufacturing hubs for active ingredients, along with dual-sourcing agreements for key components, will enhance operational resilience and reduce exposure to import levies. Incorporating advanced analytics into demand-planning processes can further mitigate risks associated with lead-time fluctuations.

Distribution strategies should prioritize omnichannel integration, linking hospital procurement systems, retail partnerships, and online platforms. Tailoring marketing messages for each end user segment-clinicians, home-care providers, and patients-will safeguard adherence and reinforce brand credibility. Finally, forging collaborations with telehealth providers and women's health advocacy groups can amplify educational outreach and drive product acceptance.

Detailing a Rigorous Research Methodology Incorporating Expert Interviews, Data Triangulation, Statistical Analysis, and Validation Protocols to Ensure Credibility

This analysis is built on a rigorous research framework combining primary and secondary methodologies. Expert interviews were conducted with leading gynecologists, procurement officers, and formulation scientists to capture firsthand perspectives on clinical efficacy, patient adherence, and operational challenges. In parallel, secondary research involved a systematic review of peer-reviewed journals, regulatory databases, and patent filings to validate technological trends and safety standards.

Quantitative data were obtained through structured surveys of hospital pharmacy directors and online pharmacy operators, enabling cross-validation of distribution insights. Data triangulation techniques reconciled discrepancies, ensuring consistency across regional and application-specific findings. Statistical analysis, including variance testing and correlation matrices, provided the basis for identifying significant drivers and performance differentials.

Validation protocols included iterative peer review by subject matter experts and sensitivity analyses to assess the impact of key variables. Ethical considerations and confidentiality agreements were upheld throughout the process, guaranteeing that all findings adhere to the highest standards of research integrity.

Synthesizing Core Findings and Implications to Effectively Conclude the Thorough Examination of Vaginal Antibacterial Gel Landscape and Future Directions

Bringing together insights on technological innovation, regulatory landscapes, and supply chain imperatives reveals a multifaceted picture of the vaginal antibacterial gel market. The convergence of advanced delivery systems, stringent compliance requirements, and evolving patient preferences underscores the need for strategic agility and continuous product optimization.

Segmentation analysis highlights the importance of tailoring formulations to active ingredient properties, application nuances, distribution environments, end user behaviors, packaging modalities, and pricing expectations. Regional dynamics demonstrate that success requires customization-whether aligning with reimbursement policies in the Americas, navigating diverse regulations in EMEA, or tapping burgeoning demand in Asia-Pacific.

Competitive profiling and actionable recommendations point toward a future where sustainability, digital integration, and collaborative partnerships will define market leadership. Decision makers who embrace these imperatives will be well positioned to capitalize on growth opportunities and deliver improved clinical outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Active Ingredient
    • Benzalkonium Chloride
    • Chlorhexidine Gluconate
    • Povidone Iodine
  • Application
    • Bacterial Vaginosis
      • Acute Bacterial Vaginosis
      • Recurrent Bacterial Vaginosis
    • Postoperative Infection Prevention
    • Surgical Prophylaxis
      • Intraoperative Prophylaxis
      • Preoperative Prophylaxis
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • End User
    • Clinics
    • Home Care
    • Hospitals
  • Packaging Type
    • Pump Dispenser
    • Sachet
    • Tube Pack
  • Price Tier
    • Economy
    • Midrange
    • Premium
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Johnson & Johnson
  • Pfizer Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Dr. Reddy's Laboratories Limited
  • Lupin Limited
  • Mayne Pharma Group Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in personalized vaginal microbiome-friendly gels with precision antibacterial activity against pathogenic strains fueling market expansion
5.2. Integration of probiotic and prebiotic blend technologies in antibacterial vaginal gels to promote healthy flora balance and infection prevention
5.3. Development of sustained-release nanosilver nanoparticle antibacterial gels for targeted vaginal infection management and extended efficacy
5.4. Increasing adoption of over-the-counter non-antibiotic antiseptic vaginal gels to address antibiotic resistance and consumer self-care trends
5.5. Emergence of digital health platforms offering prescription and monitoring of antibacterial vaginal gels through telemedicine services and remote consultations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vaginal Antibacterial Gel Market, by Active Ingredient
8.1. Introduction
8.2. Benzalkonium Chloride
8.3. Chlorhexidine Gluconate
8.4. Povidone Iodine
9. Vaginal Antibacterial Gel Market, by Application
9.1. Introduction
9.2. Bacterial Vaginosis
9.2.1. Acute Bacterial Vaginosis
9.2.2. Recurrent Bacterial Vaginosis
9.3. Postoperative Infection Prevention
9.4. Surgical Prophylaxis
9.4.1. Intraoperative Prophylaxis
9.4.2. Preoperative Prophylaxis
10. Vaginal Antibacterial Gel Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Vaginal Antibacterial Gel Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Vaginal Antibacterial Gel Market, by Packaging Type
12.1. Introduction
12.2. Pump Dispenser
12.3. Sachet
12.4. Tube Pack
13. Vaginal Antibacterial Gel Market, by Price Tier
13.1. Introduction
13.2. Economy
13.3. Midrange
13.4. Premium
14. Americas Vaginal Antibacterial Gel Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Vaginal Antibacterial Gel Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Vaginal Antibacterial Gel Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. Pfizer Inc.
17.3.3. Bayer AG
17.3.4. GlaxoSmithKline plc
17.3.5. Teva Pharmaceutical Industries Ltd.
17.3.6. Viatris Inc.
17.3.7. Sandoz International GmbH
17.3.8. Dr. Reddy's Laboratories Limited
17.3.9. Lupin Limited
17.3.10. Mayne Pharma Group Limited
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. VAGINAL ANTIBACTERIAL GEL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. VAGINAL ANTIBACTERIAL GEL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. VAGINAL ANTIBACTERIAL GEL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. VAGINAL ANTIBACTERIAL GEL MARKET: RESEARCHAI
FIGURE 28. VAGINAL ANTIBACTERIAL GEL MARKET: RESEARCHSTATISTICS
FIGURE 29. VAGINAL ANTIBACTERIAL GEL MARKET: RESEARCHCONTACTS
FIGURE 30. VAGINAL ANTIBACTERIAL GEL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VAGINAL ANTIBACTERIAL GEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY CHLORHEXIDINE GLUCONATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY CHLORHEXIDINE GLUCONATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY POVIDONE IODINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY POVIDONE IODINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACUTE BACTERIAL VAGINOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACUTE BACTERIAL VAGINOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY RECURRENT BACTERIAL VAGINOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY RECURRENT BACTERIAL VAGINOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY POSTOPERATIVE INFECTION PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY POSTOPERATIVE INFECTION PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY INTRAOPERATIVE PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY INTRAOPERATIVE PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PREOPERATIVE PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PREOPERATIVE PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PUMP DISPENSER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PUMP DISPENSER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SACHET, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SACHET, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY TUBE PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY TUBE PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ECONOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ECONOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY MIDRANGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY MIDRANGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PREMIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PREMIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 106. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 107. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 110. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 111. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 112. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 113. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 120. CANADA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 121. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 122. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 123. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 136. MEXICO VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 203. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 204. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 205. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 216. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 218. GERMANY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 219. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 220. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 221. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 232. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 234. FRANCE VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 251. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 252. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 253. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 256. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 257. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 258. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 259. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 264. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 265. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 266. ITALY VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 267. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 268. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 269. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 280. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 281. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 282. SPAIN VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY BACTERIAL VAGINOSIS, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY SURGICAL PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA VAGINAL ANTIBACTERIAL GEL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 313. SAUDI A

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vaginal Antibacterial Gel Market report include:
  • Johnson & Johnson
  • Pfizer Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Dr. Reddy's Laboratories Limited
  • Lupin Limited
  • Mayne Pharma Group Limited

Related Topics

Related Reports

Women's Intimate Care Products Market Overview, 2024-29 - Product Image

Women's Intimate Care Products Market Overview, 2024-29

  • Report
  • 102 Pages
  • Global
From
Vaginal and Vulval Inflammatory Disease Treatment Market Report 2025 - Product Image

Vaginal and Vulval Inflammatory Disease Treatment Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Vaginal Moisturizers & Lubricants Market by Product Type (Creams, Gels, Lotions), Formulation (Oil Based, Silicone Based, Water Based), Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Vaginal Moisturizers & Lubricants Market by Product Type (Creams, Gels, Lotions), Formulation (Oil Based, Silicone Based, Water Based), Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Feminine Douching Products Market by Product Type (Douche Liquids, Vaginal Douche Kits, Vaginal Sprays), Distribution Channel (Mass Retailers, Online Retailers, Pharmacies), Form, Ingredient Type, Price Tier, Packaging Type - Global Forecast 2025-2030 - Product Image

Feminine Douching Products Market by Product Type (Douche Liquids, Vaginal Douche Kits, Vaginal Sprays), Distribution Channel (Mass Retailers, Online Retailers, Pharmacies), Form, Ingredient Type, Price Tier, Packaging Type - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Vaginal Applicators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company) - Product Image

Vaginal Applicators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company)

  • Report
  • 205 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.